Nawfal Istfan1, Wendy A Anderson2, Caroline Apovian3, Megan Ruth3, Brian Carmine2, Donald Hess2. 1. Section of Endocrinology, Diabetes and Nutrition, Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts. Electronic address: Nawfal.istfan@bmc.org. 2. Department of Surgery, Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts. 3. Section of Endocrinology, Diabetes and Nutrition, Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts.
Abstract
BACKGROUND: It is known that African American (AA) patients with obesity achieve less weight loss after Roux-en-Y gastric bypass surgery (RYGB) than their Caucasian (CA) counterparts. However, it is unclear how these differences in weight loss are reflected in clinical outcomes. OBJECTIVES: To determine the effects of RYGB on hemoglobin A1c (A1c) and blood lipids in relationship to the variability in weight loss outcomes in a racially mixed patient population. SETTING: University medical center. METHODS: Retrospective analysis of clinical data from electronic medical records of CA, AA, and Hispanic American (HA) patients undergoing RYGB. RESULTS: We used 2-way cluster analysis and identified 4 distinct weight loss×race clusters. CA patients separated into 2 clusters (45.5% and 28.2% weight loss, respectively), whereas, AA and HA patients separated into 1 cluster each (33.2% and 34.4% weight loss, respectively). Factors that significantly affected weight loss were race, age, gender, and physical activity as well as presence of hypertension and degenerative joint disease. Although all clusters had significant improvements in blood lipids, HA had an increase in total cholesterol (Total-c) and low-density lipoprotein cholesterol (LDL-c) at 2 years after surgery. All clusters had significant decreases in A1c in the first year. At 2 years after RYGB, A1c levels remained stable in CA and HA; however, AA had a significant increase. These racial differences in A1c could not be explained by the smaller weight loss in AA patients. CONCLUSION: Race is an important factor in the clinical outcomes of RYGB, especially in regard to diabetes control; however, its effect is not completely understood.
BACKGROUND: It is known that African American (AA) patients with obesity achieve less weight loss after Roux-en-Y gastric bypass surgery (RYGB) than their Caucasian (CA) counterparts. However, it is unclear how these differences in weight loss are reflected in clinical outcomes. OBJECTIVES: To determine the effects of RYGB on hemoglobin A1c (A1c) and blood lipids in relationship to the variability in weight loss outcomes in a racially mixed patient population. SETTING: University medical center. METHODS: Retrospective analysis of clinical data from electronic medical records of CA, AA, and Hispanic American (HA) patients undergoing RYGB. RESULTS: We used 2-way cluster analysis and identified 4 distinct weight loss×race clusters. CA patients separated into 2 clusters (45.5% and 28.2% weight loss, respectively), whereas, AA and HA patients separated into 1 cluster each (33.2% and 34.4% weight loss, respectively). Factors that significantly affected weight loss were race, age, gender, and physical activity as well as presence of hypertension and degenerative joint disease. Although all clusters had significant improvements in blood lipids, HA had an increase in total cholesterol (Total-c) and low-density lipoprotein cholesterol (LDL-c) at 2 years after surgery. All clusters had significant decreases in A1c in the first year. At 2 years after RYGB, A1c levels remained stable in CA and HA; however, AA had a significant increase. These racial differences in A1c could not be explained by the smaller weight loss in AA patients. CONCLUSION: Race is an important factor in the clinical outcomes of RYGB, especially in regard to diabetes control; however, its effect is not completely understood.
Authors: Paul T Kröner Florit; Juan E Corral Hurtado; Karn Wijarnpreecha; Enrique F Elli; Frank J Lukens Journal: Obes Surg Date: 2019-11 Impact factor: 4.129
Authors: Michael H Wood; Arthur M Carlin; Amir A Ghaferi; Oliver A Varban; Abdelkader Hawasli; Aaron J Bonham; Nancy J Birkmeyer; Jonathan F Finks Journal: JAMA Surg Date: 2019-05-15 Impact factor: 14.766
Authors: Dylan D Thomas; Wendy A Anderson; Caroline M Apovian; Donald T Hess; Liqun Yu; Amanda Velazquez; Brian Carmine; Nawfal W Istfan Journal: Obesity (Silver Spring) Date: 2018-11-13 Impact factor: 5.002
Authors: Wasif Abidi; Eirini Nestoridi; Henry Feldman; Margaret Stefater; Clary Clish; Christopher C Thompson; Nicholas Stylopoulos Journal: Dig Dis Sci Date: 2019-08-05 Impact factor: 3.199
Authors: Nawfal W Istfan; Marine Lipartia; Wendy A Anderson; Donald T Hess; Caroline M Apovian Journal: J Clin Endocrinol Metab Date: 2021-01-01 Impact factor: 5.958
Authors: Tayler J James; Stephen F Sener; James D Nguyen; Marc Rothschild; Lauren Hawley; Tanu A Patel; Rachel Sargent; Adrian Dobrowolsky Journal: Obes Surg Date: 2021-07-02 Impact factor: 4.129
Authors: Noyan Gokce; Shakun Karki; Alyssa Dobyns; Elaina Zizza; Emily Sroczynski; Joseph N Palmisano; Celestina Mazzotta; Naomi M Hamburg; Luise I Pernar; Brian Carmine; Cullen O Carter; Michael LaValley; Donald T Hess; Caroline M Apovian; Melissa G Farb Journal: JAMA Netw Open Date: 2021-07-01
Authors: Leonard K Welsh; Andrew R Luhrs; Gerardo Davalos; Ramon Diaz; Andres Narvaez; Juan Esteban Perez; Reginald Lerebours; Maragatha Kuchibhatla; Dana D Portenier; Alfredo D Guerron Journal: Obes Surg Date: 2020-08 Impact factor: 3.479